By | August 24, 2021
Fully FDA Approved Comirnaty Pfizer

It is good news that FDA approved the first Vaccine in the world with the name of COMIRNATY, a Fully FDA Approved Comirnaty Pfizer Vaccine, That is Pfizer made this vaccine worldwide use in the way of emergency use. But Now that is a great news for whole world population who suffered Covid-19 that the Pfizer Comirnaty Vaccine will be available in the whole markets of the world with easy approaches and in easy hand with full efficacy.

I am from Pakistan and this news excited me that in Pakistan this Covid-19 Vaccine with the name Pfizer Comirnaty Vaccine will available in easy hands. Now the stress level will be resolved cause if the FDA approves this vaccine.

Read: Ashwagandha in Urdu

One thing for the health professionals is that there is no change in the old Pfizer Vaccine that is already available in the world for emergency use. After collecting the user’s Data gathering of this vaccine the FDA approved this Pfizer Old Vaccine with a new patent Name Pfizer Comirnaty Vaccine for Covid-19. There are no changes in the formulation.

Now Be Happy and Stay Safe with Pfizer Comirnaty Vaccine for Covid-19,

On August 23, 2021, FDA announced the first approval of a COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and the approved vaccine is marketed as Comirnaty, for the prevention of COVID-19 in individuals 12 years of age and older.

Pfizer-BioNTech COVID-19 Vaccine is authorized for emergency use as a:

  • Three-dose primary series for individuals 6 months through 4 years of age.
  • Two-dose primary series for individuals 5 years of age and older.
  • Third primary series dose for individuals 5 years of age and older who have been determined to have certain kinds of immunocompromise.
  • Single booster dose for individuals 5 through 11 years of age at least five months after completing a primary series of the Pfizer-BioNTech COVID-19 Vaccine.
  • First booster dose for individuals 12 years of age and older at least five months after completing a primary series of the Pfizer-BioNTech COVID-19 Vaccine or Comirnaty vaccine.
  • First booster dose for individuals 18 years of age and older who have completed primary vaccination with another authorized or approved COVID-19 vaccine. The dosing interval for this first booster dose is the same as that authorized for a booster dose of the vaccine used for primary vaccination.
  • Second booster dose for individuals 50 years of age and older at least four months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine.
  • Second booster dose for individuals 12 years of age and older with certain kinds of immunocompromise at least four months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine.

On February 11, 2022, in consultation with FDA, CDC updated the emergency use instructions to provide information about the primary, additional, and booster doses of the Pfizer COVID-19 vaccines in certain individuals.

Source of This Article: Comirnaty and Pfizer-BioNTech COVID-19 Vaccine

Mesothelioma

Leave a Reply

Your email address will not be published.

CommentLuv badge